Skip to main content
Top
Published in: Clinical & Experimental Metastasis 6/2016

Open Access 01-08-2016 | Research Paper

Soft tissue invasion of papillary thyroid carcinoma

Authors: Jen-Der Lin, Chuen Hsueh, Tzu-Chieh Chao

Published in: Clinical & Experimental Metastasis | Issue 6/2016

Login to get access

Abstract

Extrathyroidal extension (ETE) of papillary thyroid carcinoma (PTC) is common and clinical presentation can vary from minimal to extensive locoregional involvement. Although PTC is generally considered the most benign among all thyroid carcinomas, it may present with local invasion with poor prognosis. Our retrospective study involved 3267 PTC patients undergoing regular follow-up at Chang Gung Medical Center in Linkou, Taiwan. Among them, 269 were PTC cases with ETE, having tumors greater than 1 cm in size and treated with total or complete thyroidectomy with or without lymph node dissection for which the follow-up period was over 10 years. The mean age of 269 cases was 46.8 ± 15.1 (range 11–83 years) years. The number of females was 204 (75.8 %). Patients were categorized into minimal ETE (175 cases) and extensive ETE (94 cases) groups according to surgical findings and pathological reports. Mean follow-up period was 13.3 ± 5.5 (range 0.2–29.3) years, during which 28 (10.4 %) patients died of thyroid cancer; and 63 (23.4 %) of all-cause mortality. Multivariate analysis showed that age, gender, extensive ETE, and lymph node metastasis had a statistically significant effect on thyroid cancer mortality. Survival rates were significantly different between minimal ETE and extensive ETE groups (p < 0.0001). In conclusion, perithyroidal soft tissue involvement by PTC is an important factor that determines patient prognosis and a closer follow-up and more aggressive treatment is necessary for patients who are old, male, extensive ETE, and with lymph node involvement.
Literature
1.
go back to reference Grogan RH, Kaplan SP, Cao H et al (2013) A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. Surgery 154:1436–1446CrossRefPubMed Grogan RH, Kaplan SP, Cao H et al (2013) A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. Surgery 154:1436–1446CrossRefPubMed
2.
go back to reference Lin JD, Hsieh SH, Chang HY et al (2001) Outcome after treatment for papillary thyroid cancer. Head Neck 23:140–146CrossRefPubMed Lin JD, Hsieh SH, Chang HY et al (2001) Outcome after treatment for papillary thyroid cancer. Head Neck 23:140–146CrossRefPubMed
3.
go back to reference Sobin LH, UICC (2002) Wittekind C (ed) TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York, pp 52–56 Sobin LH, UICC (2002) Wittekind C (ed) TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York, pp 52–56
4.
go back to reference Nishida T, Nakao K, Hashimoto T (2000) Local control in differentiated thyroid carcinoma with extrathyroidal invasion. Am J Surg 179:86–91CrossRefPubMed Nishida T, Nakao K, Hashimoto T (2000) Local control in differentiated thyroid carcinoma with extrathyroidal invasion. Am J Surg 179:86–91CrossRefPubMed
5.
go back to reference Suh YJ, Kwon H, Kim SJ et al (2015) Factors affecting the locoregional recurrence of conventional papillary thyroid carcinoma after surgery: a retrospective analysis of 3381 patients. Ann Surg Oncol 22:3543–3549CrossRefPubMed Suh YJ, Kwon H, Kim SJ et al (2015) Factors affecting the locoregional recurrence of conventional papillary thyroid carcinoma after surgery: a retrospective analysis of 3381 patients. Ann Surg Oncol 22:3543–3549CrossRefPubMed
6.
go back to reference Moritani S (2014) Impact of invasive extranodal extension on the prognosis of patients with papillary thyroid carcinoma. Thyroid 24:1779–1783CrossRefPubMed Moritani S (2014) Impact of invasive extranodal extension on the prognosis of patients with papillary thyroid carcinoma. Thyroid 24:1779–1783CrossRefPubMed
7.
go back to reference DeLellis R, Lioyd R, Heitz P, Eng C (eds) (2004) Pathology and genetics of tumors of endocrine organs. In: World Health Organization of Tumours. IARC, Lyon, pp 73–76 DeLellis R, Lioyd R, Heitz P, Eng C (eds) (2004) Pathology and genetics of tumors of endocrine organs. In: World Health Organization of Tumours. IARC, Lyon, pp 73–76
8.
go back to reference Zhang DD, Zhou XH, Freeman DH et al (2002) A non-parametric method for the comparison of partial areas under ROC curves and its application to large health care data sets. Stat Med 21:701–715CrossRefPubMed Zhang DD, Zhou XH, Freeman DH et al (2002) A non-parametric method for the comparison of partial areas under ROC curves and its application to large health care data sets. Stat Med 21:701–715CrossRefPubMed
9.
go back to reference Verburg FA, Mäder U, Tanase K et al (2013) Life expectancy is reduced in differentiated thyroid cancer patients ≥45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients. J Clin Endocrinol Metab 98:172–180CrossRefPubMed Verburg FA, Mäder U, Tanase K et al (2013) Life expectancy is reduced in differentiated thyroid cancer patients ≥45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients. J Clin Endocrinol Metab 98:172–180CrossRefPubMed
10.
go back to reference Krämer JA, Schmid KW, Dralle H, MSDS Study Group et al (2010) Primary tumour size is a prognostic parameter in patients suffering from differentiated thyroid carcinoma with extrathyroidal growth: results of the MSDS trial. Eur J Endocrinol 163:637–644CrossRefPubMed Krämer JA, Schmid KW, Dralle H, MSDS Study Group et al (2010) Primary tumour size is a prognostic parameter in patients suffering from differentiated thyroid carcinoma with extrathyroidal growth: results of the MSDS trial. Eur J Endocrinol 163:637–644CrossRefPubMed
11.
go back to reference Kin WY, Kim HY, Son GS et al (2014) Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma. J Can Res Ther 10:50–55CrossRef Kin WY, Kim HY, Son GS et al (2014) Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma. J Can Res Ther 10:50–55CrossRef
12.
go back to reference Hotomi M, Sugitani I, Toda K et al (2012) A novel definition of extrathyroidal invasion for patients with papillary thyroid carcinoma for predicting prognosis. World J Surg 36:1231–1240CrossRefPubMed Hotomi M, Sugitani I, Toda K et al (2012) A novel definition of extrathyroidal invasion for patients with papillary thyroid carcinoma for predicting prognosis. World J Surg 36:1231–1240CrossRefPubMed
13.
14.
go back to reference Grogan RH, Kaplan SP, Cao H et al (2013) A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. Surgery 154:1436–1446CrossRefPubMed Grogan RH, Kaplan SP, Cao H et al (2013) A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. Surgery 154:1436–1446CrossRefPubMed
15.
go back to reference Shah PK, Shah KK, Karakousis GC et al (2012) Regional recurrence after lymphadenectomy for clinically evident lymph node metastases from papillary thyroid cancer: a cohort study. Ann Surg Oncol 19:1453–1459CrossRefPubMed Shah PK, Shah KK, Karakousis GC et al (2012) Regional recurrence after lymphadenectomy for clinically evident lymph node metastases from papillary thyroid cancer: a cohort study. Ann Surg Oncol 19:1453–1459CrossRefPubMed
16.
go back to reference Kruijff S, Petersen JF, Chen P et al (2014) Patterns of structural recurrence in papillary thyroid cancer. World J Surg 38:653–659CrossRefPubMed Kruijff S, Petersen JF, Chen P et al (2014) Patterns of structural recurrence in papillary thyroid cancer. World J Surg 38:653–659CrossRefPubMed
17.
go back to reference Barczyński M, Konturek A, Stopa M et al (2014) Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer. Langenbecks Arch Surg 399:237–244CrossRefPubMed Barczyński M, Konturek A, Stopa M et al (2014) Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer. Langenbecks Arch Surg 399:237–244CrossRefPubMed
18.
go back to reference Kim HJ, Sohn SY, Jang HW et al (2013) Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. World J Surg 37:376–384CrossRefPubMed Kim HJ, Sohn SY, Jang HW et al (2013) Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. World J Surg 37:376–384CrossRefPubMed
19.
go back to reference Nishida T, Nakao K, Hashimoto T (2000) Local control in differentiated thyroid carcinoma with extrathyroidal invasion. Am J Surg 179:86–91CrossRefPubMed Nishida T, Nakao K, Hashimoto T (2000) Local control in differentiated thyroid carcinoma with extrathyroidal invasion. Am J Surg 179:86–91CrossRefPubMed
20.
go back to reference Lee EK, Lee YJ, Jung YS et al (2015) Postoperative simultaneous integrated boost-intensity modulated radiation therapy for patients with locoregionally advanced papillary thyroid carcinoma: preliminary results of a phase II trial and propensity score analysis. J Clin Endocrinol Metab 100:1009–1017CrossRefPubMed Lee EK, Lee YJ, Jung YS et al (2015) Postoperative simultaneous integrated boost-intensity modulated radiation therapy for patients with locoregionally advanced papillary thyroid carcinoma: preliminary results of a phase II trial and propensity score analysis. J Clin Endocrinol Metab 100:1009–1017CrossRefPubMed
21.
go back to reference Lin JD, Hsueh C, Chao TC (2015) Long-term follow-up of the therapeutic outcomes for papillary thyroid carcinoma with distant metastasis. Medicine 94(26):e1063CrossRefPubMedPubMedCentral Lin JD, Hsueh C, Chao TC (2015) Long-term follow-up of the therapeutic outcomes for papillary thyroid carcinoma with distant metastasis. Medicine 94(26):e1063CrossRefPubMedPubMedCentral
23.
go back to reference Chen ST, Hsueh C, Chiou WK et al (2013) Disease-specific mortality and secondary primary cancer in well-differentiated thyroid cancer with type 2 diabetes mellitus. PLoS ONE 8(1):e55179CrossRefPubMedPubMedCentral Chen ST, Hsueh C, Chiou WK et al (2013) Disease-specific mortality and secondary primary cancer in well-differentiated thyroid cancer with type 2 diabetes mellitus. PLoS ONE 8(1):e55179CrossRefPubMedPubMedCentral
24.
go back to reference Young S, Harari A, Smooke-Praw S et al (2013) Effect of reoperation on outcomes in papillary thyroid cancer. Surgery 154:1354–1361CrossRefPubMed Young S, Harari A, Smooke-Praw S et al (2013) Effect of reoperation on outcomes in papillary thyroid cancer. Surgery 154:1354–1361CrossRefPubMed
Metadata
Title
Soft tissue invasion of papillary thyroid carcinoma
Authors
Jen-Der Lin
Chuen Hsueh
Tzu-Chieh Chao
Publication date
01-08-2016
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 6/2016
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-016-9800-3

Other articles of this Issue 6/2016

Clinical & Experimental Metastasis 6/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine